Aytu BioPharma, Inc. (AYTU)

NASDAQ: AYTU · IEX Real-Time Price · USD
0.290
-0.002 (-0.62%)
At close: Aug 12, 2022 4:00 PM
0.288
-0.001 (-0.380%)
After-hours: Aug 12, 2022 7:58 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Year 20212020201920182017201620152014
Revenue
65.6327.637.323.663.222.560.260.06
Revenue Growth (YoY)
137.52%277.47%100.00%13.61%25.72%878.85%344.23%-
Cost of Revenue
36.438.282.22.051.420.960.090
Gross Profit
29.219.355.121.611.81.610.170.06
Selling, General & Admin
55.8131.0619.2417.7317.618.834.292.35
Research & Development
5.621.720.590.171.356.323.424.06
Other Operating Expenses
26.647.72.143.412.978.160.090
Operating Expenses
88.0740.4821.9621.3121.9323.317.816.41
Operating Income
-58.87-21.13-16.85-19.7-20.13-21.7-7.63-6.35
Interest Expense / Income
00002.535.490.110.05
Other Expense / Income
-0.84-7.5110.29-9.51-0.150.9800
Pretax Income
-58.03-13.62-27.13-10.19-22.51-28.18-7.75-6.39
Income Tax
0.2600000-0.02-0.81
Net Income
-58.29-13.62-27.13-10.19-22.51-28.18-7.72-5.58
Net Income Common
-58.29-13.62-27.13-10.19-22.51-28.18-7.72-5.58
Shares Outstanding (Basic)
175100000
Shares Outstanding (Diluted)
175100000
Shares Change
270.57%479.79%1071.05%42.83%10613.10%126.56%32.41%-
EPS (Basic)
-3.48-3.01-34.80-153.10-483.00-64740.00-40280.00-38400.00
EPS (Diluted)
-3.48-3.01-34.80-153.10-483.00-64740.00-40280.00-38400.00
Free Cash Flow Per Share
-1.55-6.28-17.82-240.61-299.15-25064.91-34583.46-38066.18
Gross Margin
44.50%70.00%69.90%44.00%56.00%62.60%66.30%100.00%
Operating Margin
-89.70%-76.50%-230.10%-538.20%-624.70%-847.00%-2915.50%-10770.30%
Profit Margin
-88.80%-49.30%-370.60%-278.30%-698.70%-1099.70%-2950.30%-9466.80%
Free Cash Flow Margin
-39.60%-102.70%-189.80%-437.60%-432.70%-425.80%-2534.30%-9352.40%
Effective Tax Rate
-0.45%0.00%0.00%0.00%0.00%0.00%0.31%12.73%
EBITDA
-48.83-7.91-24.4-7.6-15.61-21.81-7.51-6.25
EBITDA Margin
-74.40%-28.60%-333.40%-207.60%-484.50%-851.30%-2870.40%-10604.90%
Depreciation & Amortization
9.25.712.732.594.360.870.120.1
EBIT
-58.03-13.62-27.13-10.19-19.97-22.69-7.63-6.35
EBIT Margin
-88.40%-49.30%-370.60%-278.30%-620.00%-885.40%-2915.50%-10770.30%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).